As the mRNA industry rapidly expands into rare and oncological disease indications, in addition to infectious diseases beyond COVID, the 4th mRNA-Based Therapeutics Summit returns with a refreshed, comprehensive program spanning every stage of drug development. Engage with fresh content and networking opportunities to de-risk your pipeline, maximize therapeutic impact, and successfully bring mRNA-based therapeutics and vaccines to market to address unmet clinical needs.
Unmissable Agenda Highlights Include:
Advance the next frontiers of mRNA-based therapeutic and vaccine strategies to stay ahead of the curve at the brand-new CEOs’ Panel Discussion with CureVac, Arcturus Therapeutics, Sail Biomedicines and more
Uncover the mRNA regulatory and industry landscapes for cancer, rare, and infectious diseases to harmonize expectations with the FDA, EMA, GSK and more
Showcasing the latest clinical results from Moderna’s mRNA trials for melanoma, acidemias, and norovirus, paving the way towards the next successful approval for patients
Explore the brand-new Pre-Conference Day, with two streams of focused content on Next Generation mRNA Delivery and Regulatory Affairs Strategy, and Wellcome Leap’s Breakthrough Innovations Workshop to fast-track development and approvals of mRNA-based drugs to patients faster
Access the Agenda to Explore:
Attendees from Large Pharma, Biotech & Academia
Pre-Conference Focus Days
See the 2023 Event Highlights
Watch our event highlights video to find out what you can look forward to in 2024!